SibEnzyme

Executive Summary

SibEnzyme is a Russian biotechnology company headquartered in Novosibirsk, specializing in the development and production of enzymes and reagents for molecular biology research. Founded in 1998, the company's core product line includes restriction endonucleases, DNA polymerases, methyltransferases, nucleotides, DNA markers, and associated buffers and substrates. All products are explicitly labeled for research use only, not for medical or diagnostic applications. SibEnzyme operates as a private entity with no disclosed financials, valuation, or employee count. Given its focus on niche molecular biology tools and its location in Russia, the company faces challenges related to international market access and geopolitical risks. However, its long-standing presence in the field suggests a stable position within the research reagent supply chain. Growth prospects are limited by the lack of visible pipeline expansion or recent milestones, making it a low-conviction opportunity in the near term.

Upcoming Catalysts (preview)

• TBDExpansion of product portfolio into next-generation sequencing (NGS) enzymes30% success
• TBDStrategic partnership or distribution agreement with a Western life sciences company20% success
• TBDLaunch of a new line of recombinant proteins for CRISPR or gene editing research25% success